Organization · Micro VC
Imbolc Partners
Imbolc Partners is a micro-venture capital firm that invests in pre-seed and seed-stage companies across various sectors, including healthcare and AI. Based in the United States, it focuses on capital-efficient businesses with strong founder potential.
Overview
What Imbolc Partners does
What Imbolc Partners is
Imbolc Partners is a micro-venture capital firm that invests in pre-seed and seed-stage companies across various sectors, including healthcare and AI. Based in the United States, it focuses on capital-efficient businesses with strong founder potential.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Micro VC
- Founded
- Founded in 2024
- Approximate age
- About 2 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find Imbolc Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Imbolc Partners as a funder
Investment thesis
Imbolc Partners invests in early-stage companies that may be overlooked by other VCs, focusing on smaller deals, niche markets, and capital-efficient models with a clear path to revenue and potential for M&A.
Focus narrative
Imbolc Partners specializes in pre-seed and seed investments, typically writing checks of around $250,000. The firm reserves capital for follow-on investments in companies that demonstrate a clear pathway to revenue and profitability. Imbolc Partners seeks to partner with founders who possess high energy and integrity, particularly those in niche markets where small investments can lead to significant traction.
Value beyond capital
Imbolc Partners adds value to its portfolio companies by providing not only capital but also strategic guidance and support in navigating early-stage challenges. The firm focuses on fostering relationships with high-energy founders and offers insights into achieving revenue growth and preparing for potential mergers and acquisitions.
Terms and economics
- Typical check
- $250,000
- Sweet spot
- $250,000
Focus and fit
- Stages
- Pre-seed · Seed
- Sectors
- Healthcare · Biotech · Medical Devices · Climate · AI · Logistics · Consumer
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Jeevan Therapeutics: Developing novel therapeutics for Crohn's disease and related autoimmune disorders. Ecolumix: An environmental, health, and safety tracking data platform. Qnity Bio: Focused on quantum electrochemistry for drug discovery. Harness Care: A personalized healthcare concierge service for benefits simplification. ClearCut Surgical: Innovating smart electrocautery devices with integrated smoke evacuation. Onbrand PLM: An AI-enabled product lifecycle management platform for brand teams. Underdog: Producing premium recovery drinks and energy pouches.
Common questions
What to know about Imbolc Partners
Upseed classifies Imbolc Partners under the Micro VC organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.